IL1A and chronic obstructive pulmonary disease: As pharmacodynamic markers may also serve as predictive biomarkers of response [29], and IL-1 pathway activation has been clearly linked to neutrophilia pre-clinically in multiple animal models, we sought to evaluate efficacy of MEDI8968 in the subjects with COPD in this study by their baseline blood neutrophil counts.